Clinical Trial: Determination of the ED50 and ED95 of Remimazolam Combined with Target-Controlled Infusion of Sufentanil for Attenuating Hemodynamic Responses to Endotracheal Intubation and Laryngeal Mask Airway Insertion (China)

China, Sept. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Determination of the ED50 and ED95 of Remimazolam Combined with Target-Controlled Infusion of Sufentanil for Attenuating Hemodynamic Responses to Endotracheal Intubation and Laryngeal Mask Airway Insertion'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133564

Registration Time: 2026/09/29

Type: Interventional study

Primary Sponsor: The Affiliated Hospital of Guizhou Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=326423

Published by HT Digital Content Services with permission from Health Daily Digest....